Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/18/21 17:00 | 5/14/21 | SNGX | Health | Drug | Pharmaceutical Preparations | Zeldis Jerome B | NJ | D | S | -3 | 0.9002 | 0 | -3 | -12 | 23 | D | |||||||||||||||
12/1/17 16:25 | 11/29/17 | SNGX | Health | Drug | Pharmaceutical Preparations | Essetifin Spa | L6 | H | Former 1 | S | -622 | 2.12 | 0 | -294 | -50 | 294 | M | ||||||||||||||
5/8/17 17:30 | 5/4/17 | SNGX | Health | Drug | Pharmaceutical Preparations | Kirk Randal J | VA | T | S.dm | -502 | 3.12 | 6 | -161 | -23 | 526 | I | -82 | -67 | -33 | 16 | 17 | 3 | -18 | -13 | 0 | 2 | |||||
8/20/10 14:00 | 8/18/10 | SNGX | Health | Drug | Pharmaceutical Preparations | Bam Management LLC | NY | T | S | -46 | 0.2400 | 0 | -192 | -1 | 21,574 | I | 144 | 0 | -15 | -15 | -12 | -12 | -15 | -8 | 9 | 5 | 5 | -23 | -18 | 23 | |
8/11/09 16:18 | 7/30/09 | DOR | Health | Drug | Pharmaceutical Preparations | Biotex Pharma Investments, LLC | NY | T | S.m | -202 | 0.2025 | 0 | -1,000 | -5 | 19,000 | ||||||||||||||||
2/18/04 17:06 | 2/13/04 | DOR | Health | Drug | Pharmaceutical Preparations | Elan Corp Plc | L2 | T | S | -1,329 | 1.02 | 0 | -1,306 | -89 | 163 | I | |||||||||||||||
2/13/04 15:43 | 2/11/04 | DOR | Health | Drug | Pharmaceutical Preparations | Elan Corp Plc | L2 | T | S.m | -615 | 1.05 | 0 | -584 | -28 | 1,469 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |